These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 22714048)
1. Sulfonylurea receptor 1 in central nervous system injury: a focused review. Simard JM; Woo SK; Schwartzbauer GT; Gerzanich V J Cereb Blood Flow Metab; 2012 Sep; 32(9):1699-717. PubMed ID: 22714048 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. Simard JM; Kahle KT; Gerzanich V J Neurosurg; 2010 Sep; 113(3):622-9. PubMed ID: 20035575 [TBL] [Abstract][Full Text] [Related]
9. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. Chen M; Dong Y; Simard JM J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426 [TBL] [Abstract][Full Text] [Related]
12. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1. Sala-Rabanal M; Wang S; Nichols CG J Biol Chem; 2012 Mar; 287(12):8746-56. PubMed ID: 22291026 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner. Hambrock A; de Oliveira Franz CB; Hiller S; Grenz A; Ackermann S; Schulze DU; Drews G; Osswald H J Biol Chem; 2007 Feb; 282(5):3347-56. PubMed ID: 17138562 [TBL] [Abstract][Full Text] [Related]
14. Human oocytes express ATP-sensitive K(+) channels. Du Q; Jovanović S; Sukhodub A; Barratt E; Drew E; Whalley KM; Kay V; McLaughlin M; Telfer EE; Barratt CL; Jovanović A Hum Reprod; 2010 Nov; 25(11):2774-82. PubMed ID: 20847183 [TBL] [Abstract][Full Text] [Related]
15. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485 [TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review. Jha RM; Rani A; Desai SM; Raikwar S; Mihaljevic S; Munoz-Casabella A; Kochanek PM; Catapano J; Winkler E; Citerio G; Hemphill JC; Kimberly WT; Narayan R; Sahuquillo J; Sheth KN; Simard JM Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769328 [TBL] [Abstract][Full Text] [Related]
17. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T). Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272 [TBL] [Abstract][Full Text] [Related]
18. ATP-sensitive potassium currents in rat primary afferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury. Kawano T; Zoga V; McCallum JB; Wu HE; Gemes G; Liang MY; Abram S; Kwok WM; Hogan QH; Sarantopoulos CD Neuroscience; 2009 Aug; 162(2):431-43. PubMed ID: 19422886 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Simard JM; Yurovsky V; Tsymbalyuk N; Melnichenko L; Ivanova S; Gerzanich V Stroke; 2009 Feb; 40(2):604-9. PubMed ID: 19023097 [TBL] [Abstract][Full Text] [Related]
20. Abcc8 suppression reduces secondary injury after experimental SCI. Singh H; Wang MY World Neurosurg; 2010 Dec; 74(6):553-4. PubMed ID: 21492614 [No Abstract] [Full Text] [Related] [Next] [New Search]